← Back to Clinical Trials
Recruiting NCT07425730
Early Myocardial Dysfunction Helps Identify Severe Refractory Pediatric Lupus
Trial Parameters
Condition Systemic Lupus Erythematosus (SLE)
Sponsor Shanghai Jiao Tong University School of Medicine
Study Type OBSERVATIONAL
Phase N/A
Enrollment 60
Sex ALL
Min Age 7 Years
Max Age 17 Years
Start Date 2026-02
Completion 2026-07
Brief Summary
To investigate biomarkers to identify pediatric SR-SLE patients by non-invasive echocardiographic techniques.
Eligibility Criteria
Inclusion Criteria: * fulfill the American College of Rheumatology (ACR) criteria * disease onset at ages before 18 years Exclusion Criteria: * patients with a history of concomitant malignancy * patients with active bacterial, viral, fungal, mycobacterial infection
Related Trials
NCT06789107
Blinatumomab in Refractory Active Childhood Systemic Lupus Erythematosus
View Trial →
NCT06675422
JY231 Injection for the Treatment of Active Systemic Lupus Erythematosus (SLE)
View Trial →
NCT07413341
A Clinical Study of TI-0032-III Injection in Patients With Relapsed and Refractory Autoimmune Diseas
View Trial →